Molteni C - Search Results

1

Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study.

De Vito A, Ricci E, Menzaghi B, Orofino G, Martinelli CV, Squillace N, Taramasso L, De Socio GV, Molteni C, Valsecchi L, Costa C, Celesia BM, Parruti G, Pellicanò GF, Sarchi E, Cascio A, Cenderello G, Falasca K, Di Biagio A, Bonfanti P, Madeddu G. De Vito A, et al. Among authors: molteni c. Viruses. 2023 Mar 10;15(3):720. doi: 10.3390/v15030720. Viruses. 2023. PMID: 36992429 Free PMC article.

2

PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy.

Molteni CG, Te Kronnie G, Bicciato S, Villa T, Tartaglia M, Basso G, Biondi A, Cazzaniga G. Molteni CG, et al. Leukemia. 2010 Jan;24(1):232-5. doi: 10.1038/leu.2009.200. Epub 2009 Sep 24. Leukemia. 2010. PMID: 19776760 No abstract available.

3

Genomic analysis of different clonal evolution in a twin pair with t(12;21) positive acute lymphoblastic leukemia sharing the same prenatal clone.

Bungaro S, Irving J, Tussiwand R, Mura R, Minto L, Molteni C, Citterio M, Hall A, Biondi A, Cazzaniga G. Bungaro S, et al. Among authors: molteni c. Leukemia. 2008 Jan;22(1):208-11. doi: 10.1038/sj.leu.2404973. Epub 2007 Oct 11. Leukemia. 2008. PMID: 17914410 No abstract available.

4

Aberrant GM-CSF signal transduction pathway in juvenile myelomonocytic leukemia assayed by flow cytometric intracellular STAT5 phosphorylation measurement.

Gaipa G, Bugarin C, Longoni D, Cesana S, Molteni C, Faini A, Timeus F, Zecca M, Biondi A. Gaipa G, et al. Among authors: molteni c. Leukemia. 2009 Apr;23(4):791-3. doi: 10.1038/leu.2008.265. Epub 2008 Oct 2. Leukemia. 2009. PMID: 18830265 No abstract available.

5

Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort.

Vescini F, Cozzi-Lepri A, Borderi M, Re MC, Maggiolo F, De Luca A, Cassola G, Vullo V, Carosi G, Antinori A, Tozzi V, Monforte AD; Icona Foundation Study Group. Vescini F, et al. J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):163-72. doi: 10.1097/QAI.0b013e31822e57e9. J Acquir Immune Defic Syndr. 2011. PMID: 21826011

6

Raltegravir central nervous system tolerability in clinical practice: results from a multicenter observational study.

Madeddu G, Menzaghi B, Ricci E, Carenzi L, Martinelli C, di Biagio A, Parruti G, Orofino G, Mura MS, Bonfanti P; C.I.S.A.I Group. Madeddu G, et al. AIDS. 2012 Nov 28;26(18):2412-5. doi: 10.1097/QAD.0b013e32835aa141. AIDS. 2012. PMID: 23032413

7

Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study.

Schillaci G, Maggi P, Madeddu G, Pucci G, Mazzotta E, Penco G, Orofino G, Menzaghi B, Rusconi S, Carenzi L, Celesia BM, Martinelli C, Bonfanti P, De Socio GV; CISAI Study Group. Schillaci G, et al. J Hypertens. 2013 Mar;31(3):560-7; discussion 567. doi: 10.1097/HJH.0b013e32835ca949. J Hypertens. 2013. PMID: 23282895

8

The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients.

Di Biagio A, Ricci E, Viscoli C, Mesini A, Menzaghi B, Carenzi L, Orofino G, Parruti G, Martinelli C, Madeddu G, De Socio GV, Franzetti M, Quirino T, Bonfanti P; CISAI Group. Di Biagio A, et al. Curr HIV Res. 2013 Apr;11(3):179-86. doi: 10.2174/1570162x113119990036. Curr HIV Res. 2013. PMID: 23432466

9

Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project).

Menzaghi B, Ricci E, Carenzi L, Parruti G, Orofino G, Guastavigna M, Madeddu G, Maggi P, Di Biagio A, Corsi P, Penco G, De Socio G, Martinelli C, Vichi F, Celesia BM, Franzetti M, Grosso C, Molteni C, Bonfanti P, Quirino T. Menzaghi B, et al. Among authors: molteni c. Biomed Pharmacother. 2013 May;67(4):293-8. doi: 10.1016/j.biopha.2012.12.005. Epub 2012 Dec 26. Biomed Pharmacother. 2013. PMID: 23433852 Clinical Trial.

10

Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.

Lapadula G, Cozzi-Lepri A, Marchetti G, Antinori A, Chiodera A, Nicastri E, Parruti G, Galli M, Gori A, Monforte Ad; ICONA Foundation Study. Lapadula G, et al. AIDS. 2013 Mar 13;27(5):769-79. doi: 10.1097/QAD.0b013e32835cb747. AIDS. 2013. PMID: 23719349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page